Investigation Report on China Trastuzumab Market, 2009-2018
Reportstack, provider of premium market research reports announces the addition of Investigation Report on China Trastuzumab Market, 2009-2018 market report to its offering
Trastuzumab is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers. Trastuzumab has a major impact in the treatment of HER2-positive metastatic breast cancers.
View full press release